Evidence map›Paper›PMID 37108415›Full record

ArticleInternational journal of molecular sciences2023

Synthesis of Novel 2-(Cyclopentylamino)thiazol-4(5

Szymon Baumgart, Daria Kupczyk, Aneta Archała, Oliwia Koszła, Przemysław Sołek, Wojciech Płaziński, Anita Płazińska, Renata Studzińska

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. New Derivatives of 2-(Cyclohexylamino)thiazol-4(5International journal of molecular sciences · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Szymon BaumgartDepartment of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 2 Jurasza Str., 85-089 Bydgoszcz, Poland.
Daria KupczykDepartment of Medical Biology and Biochemistry, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 24 Karłowicza Str., 85-092 Bydgoszcz, Poland.
Aneta ArchałaDepartment of Biopharmacy, Medical University of Lublin, 4a Chodźki Str., 20-093 Lublin, Poland.ORCID 0000-0003-4244-4382
Oliwia KoszłaDepartment of Biopharmacy, Medical University of Lublin, 4a Chodźki Str., 20-093 Lublin, Poland.ORCID 0000-0003-2160-9424
Przemysław SołekDepartment of Biopharmacy, Medical University of Lublin, 4a Chodźki Str., 20-093 Lublin, Poland.ORCID 0000-0002-6194-0042
Wojciech PłazińskiDepartment of Biopharmacy, Medical University of Lublin, 4a Chodźki Str., 20-093 Lublin, Poland.
Anita PłazińskaDepartment of Biopharmacy, Medical University of Lublin, 4a Chodźki Str., 20-093 Lublin, Poland.ORCID 0000-0002-3698-2574
Renata StudzińskaDepartment of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 2 Jurasza Str., 85-089 Bydgoszcz, Poland.ORCID 0000-0001-5853-4214
Medical University of Lublin · PLNicolaus Copernicus University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, a series of nine new 2-(cyclopentylamino)thiazol-4(5

Indexed as

11-beta-Hydroxysteroid Dehydrogenase Type 1AntioxidantsCaco-2 CellsCarbenoxoloneEnzyme InhibitorsHumansProtein Isoforms11-beta-Hydroxysteroid Dehydrogenase Type 1AntioxidantsCarbenoxoloneEnzyme InhibitorsProtein Isoforms11β-hydroxysteroid dehydrogenase 1antitumor activitymolecular dockingthiazolone derivatives

Identifiers

PMID37108415
PMCPMC10139140
OpenAlexW4365514923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.